financetom
Business
financetom
/
Business
/
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
Mar 20, 2024 6:02 AM

07:37 AM EDT, 03/20/2024 (MT Newswires) -- Hunter C Smith, Chief Financial Officer, on March 19, 2024, sold 15,515 shares in Rhythm Pharmaceuticals ( RYTM ) for $608,498. Following the Form 4 filing with the SEC, Smith has control over a total of 97,939 shares of the company, with 97,939 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649904/000110465924036319/xslF345X03/tm249308-6_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sonoma Pharmaceuticals Q2 revenue beats expectations on increased distributor sales
Sonoma Pharmaceuticals Q2 revenue beats expectations on increased distributor sales
Nov 4, 2025
Overview * Sonoma fiscal Q2 revenue grows 57% yr/yr, beating analyst expectations * Net loss per share decreases 46% for fiscal Q2 compared to last year * U.S. revenue increases 115% for fiscal Q2, driven by OTC product sales Outlook * Company expects positive growth trajectory with increasing product adoption Result Drivers * U.S. SALES GROWTH - Revenue in the...
NNN REIT Q3 Adjusted FFO, Revenue Rise
NNN REIT Q3 Adjusted FFO, Revenue Rise
Nov 4, 2025
09:03 AM EST, 11/04/2025 (MT Newswires) -- NNN REIT ( NNN ) reported Q3 adjusted funds from operations Tuesday of $0.86 per diluted share, up from $0.84 a year earlier. Analysts polled by FactSet expected $0.85. Revenue for the quarter ended Sept. 30 was $230.2 million, compared with $218.6 million a year earlier. Analysts surveyed by FactSet expected $227.1 million....
Tango Therapeutics reports Q3 net income, revenue jumps
Tango Therapeutics reports Q3 net income, revenue jumps
Nov 4, 2025
Overview * Tango Therapeutics ( TNGX ) Q3 collaboration revenue increased significantly compared to the same period in 2024 * Company reports Q3 net income, reversing a net loss from the previous year * $225 mln financing extends cash runway into 2028, supporting clinical trials Outlook * Company anticipates pivotal trial for vopimetostat in 2L MTAP-del pancreatic cancer in 2026...
Hertz surges after swinging to third-quarter profit
Hertz surges after swinging to third-quarter profit
Nov 4, 2025
(Reuters) -Hertz Global ( HTZ ) swung to a third-quarter profit after nearly two years on Tuesday, as the company relied on used vehicle sales and a newer fleet of rental cars to drive demand, sending its shares up 27% in premarket trading. The company has attempted to diversify operations by revamping its vehicle fleet and offering a fully online...
Copyright 2023-2026 - www.financetom.com All Rights Reserved